SEK175.40
1.98% today
Stockholm, May 14, 12:01 pm CET
ISIN
SE0010323311
Symbol
BIOA B
Sector
Industry

BioArctic AB Target price 2025 - Analyst rating & recommendation

BioArctic AB Classifications & Recommendation:

Buy
83%
Hold
17%

BioArctic AB Price Target

Target Price SEK292.00
Price SEK172.00
Potential
Number of Estimates 6
6 Analysts have issued a price target BioArctic AB 2026 . The average BioArctic AB target price is SEK292.00. This is higher than the current stock price. The highest price target is
SEK350.00 103.49%
register free of charge
, the lowest is
SEK240.00 39.53%
register free of charge
.
A rating was issued by 6 analysts: 5 Analysts recommend BioArctic AB to buy, 1 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the BioArctic AB stock has an average upside potential 2026 of . Most analysts recommend the BioArctic AB stock at Purchase.

Sales and Margin forecast 2025, 2026 to 2029

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '24 2025
Estimates
Revenue Million SEK 257.35 1,589.73
58.22% 517.73%
EBITDA Margin -79.75% 74.30%
278.56% 193.17%
Net Margin -68.69% 57.49%
284.13% 183.69%

7 Analysts have issued a sales forecast BioArctic AB 2025 . The average BioArctic AB sales estimate is

SEK1.6b
Unlock
. This is
517.73% higher
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
SEK2.0b 676.76%
Unlock
, the lowest is
SEK574m 123.04%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2024 SEK257m 58.22%
2025
SEK1.6b 517.73%
Unlock
2026
SEK1.3b 17.32%
Unlock
2027
SEK2.2b 71.05%
Unlock
2028
SEK3.2b 41.88%
Unlock
2029
SEK4.1b 28.65%
Unlock

3 BioArctic AB Analysts have issued a net profit forecast 2025. The average BioArctic AB net profit estimate is

SEK914m
Unlock
. This is
617.00% higher
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
SEK977m 652.50%
Unlock
, the lowest is
SEK832m 570.50%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2024 SEK-177m 176.92%
2025
SEK914m 617.00%
Unlock
2026
SEK335m 63.35%
Unlock
2027
SEK1.0b 210.90%
Unlock

Net Margin

2024 -68.69% 284.13%
2025
57.49% 183.69%
Unlock
2026
25.49% 55.66%
Unlock
2027
46.32% 81.72%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2029

Create a premium account to unlock analyst estimates. Learn more

Dec '24 2025
Estimates
Earnings Per Share SEK -2.00 10.34
176.92% 617.00%
P/E 16.63
EV/Sales 9.12

3 Analysts have issued a BioArctic AB forecast for earnings per share. The average BioArctic AB EPS is

SEK10.34
Unlock
. This is
617.00% higher
Unlock
than earnings per share in the financial year 2024. The highest EPS forecast is
SEK11.05 652.50%
Unlock
, the lowest is
SEK9.41 570.50%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2024 SEK-2.00 176.92%
2025
SEK10.34 617.00%
Unlock
2026
SEK3.79 63.35%
Unlock
2027
SEK11.78 210.82%
Unlock

P/E ratio

Current -85.80 209.94%
2025
16.63 119.38%
Unlock
2026
45.38 172.88%
Unlock
2027
14.60 67.83%
Unlock

Based on analysts' sales estimates for 2025, the BioArctic AB stock is valued at an EV/Sales of

and an P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 56.35 107.02%
2025
9.12 83.81%
Unlock
2026
11.03 20.94%
Unlock
2027
6.45 41.54%
Unlock
2028
4.55 29.52%
Unlock
2029
3.53 22.27%
Unlock

P/S ratio

Current 59.17 103.89%
2025
9.58 83.81%
Unlock
2026
11.58 20.95%
Unlock
2027
6.77 41.54%
Unlock
2028
4.77 29.51%
Unlock
2029
3.71 22.27%
Unlock

Current BioArctic AB Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
RX SECURITIES
Locked
Locked
Locked Mar 24 2025
DNB MARKETS
Locked
Locked
Locked Feb 16 2025
RX SECURITIES
Locked
Locked
Locked Jan 05 2025
DNB MARKETS
Locked
Locked
Locked Nov 17 2024
Analyst Rating Date
Locked
RX SECURITIES:
Locked
Locked
Mar 24 2025
Locked
DNB MARKETS:
Locked
Locked
Feb 16 2025
Locked
RX SECURITIES:
Locked
Locked
Jan 05 2025
Locked
DNB MARKETS:
Locked
Locked
Nov 17 2024

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today